Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Immix Biopharma, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.00.00.6
            Revenue growth  -100.0% 
Cost of goods sold0.00.00.01.2
Gross profit0.00.00.0-0.6
            Gross margin   -100.0%
Research and development4.20.10.2 
General and administrative4.01.20.20.3
EBIT-8.221.40.1-0.8
            EBIT margin   -144.5%
Pre-tax income-8.2-24.4-1.1-1.0
Income taxes0.00.00.00.0
Net income-8.2-24.4-1.1-1.0
            Net margin   -166.8%
 
Diluted EPS($0.59)($6.64)($0.34) 
Shares outstanding (diluted)13.93.73.4 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy